Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Randomized Trial of Tadalafil and Glycemic Traits

NCT01444651 is registered in ClinicalTrials.gov with Thomas J. Wang, MD as lead sponsor.

NCT NCT01444651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01444651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Randomized Trial of Tadalafil and Glycemic Traits
Lead sponsor
Thomas J. Wang, MD
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2011
Completion date
March 31, 2013
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, glucose intolerance, insulin resistance, obesity